Frida from Spain

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Merck & Co., Inc. (MRK) shares information

Merck & Co., Inc.

24h Change

0.78 %


Live rate: Market closed

Stock data per Friday 23 Oct, 2020

New York Stock Exchange
0.62 (+ 0.78%)
US Market is closed

Live Stock price in graph for Merck & Co., Inc. (MRK)

  • Latest Volume

    6,974,613 (20.3 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change


Quick links

Broker recommendations for Merck & Co.

The Merck & Co., Inc. stock is rated at 1.285714 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 21 October, 2020 by a total of 21 brokers. This means that the consensus of the 21 different brokers is leaning toward to buy/moderate buy.

0 (0%)
0 (0%)
5 (23.81%)
2 (9.52%)
14 (66.67%)

Price target by analysts

The 18 latest analyst estimates, per Wednesday 21 October, 2020, show the following high, low and average price targets.
Target Average: 95.83 USD
Target High: 107 USD
Target Low: 84 USD


Latest news about Merck & Co., Inc.

Below you can find the most recent news posts about Merck & Co., Inc., primarily from US and UK based news sources.

Merck & Co., Inc. (NYSE:MRK) Coverage Initiated at Truist

Saturday, 24 October 2020, 15:04:42
Truist assumed coverage on shares of Merck & Co., Inc. (NYSE:MRK) in a research report sent to investors on Friday, The Fly reports. The firm issued a buy rating and a $96.00 price target on the stock. Other analysts have also recently issued reports about the company. Goldman Sachs Group raised Merck & Co., Inc. […]
— Transcript Daily

Merck & Co., Inc. (NYSE:MRK) Coverage Initiated by Analysts at Truist

Saturday, 24 October 2020, 11:04:42
Truist started coverage on shares of Merck & Co., Inc. (NYSE:MRK) in a research report sent to investors on Friday morning, The Fly reports. The firm issued a buy rating and a $96.00 target price on the stock. Several other research firms have also recently commented on MRK. Royal Bank of Canada reiterated a hold […]
— Stock Observer

miRNA Kits Market to Witness Huge Growth by 2026 | Thermo Fisher Scientific, Agilent, Sigma-Aldrich(Merck)

Friday, 23 October 2020, 22:26:02
Global miRNA Kits Market Report 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers,
— OpenPR

Global Women’s Health Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 || Pfizer Inc., Merck & Co., Inc., Novo Nordisk A/S, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca

Friday, 23 October 2020, 20:22:00
The Global Women’s Health Market report offers meticulous investigation of current scenario of the global market, which considers numerous market dynamics. This market report identifies and analyses the emerging trends along with key drivers, challenges and opportunities in the ABC
— OpenPR

Why Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase

Friday, 23 October 2020, 18:33:00
Initial hesitation by senior executives about joining the global effort puts the company in an unusual spot: behind.
— The Wall Street Journal

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: offer a large number of stocks for trading. Register an account today and check if they have MRK available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.